An improved whole cell pertussis vaccine with reduced content of endotoxin. - Wikidata - awgldk - TriplyDB

An improved whole cell pertussis vaccine with reduced content of endotoxin.

An improved whole cell pertussis vaccine with reduced content of endotoxin.

http://www.wikidata.org/entity/Q37384751

about

Bordetella pertussis pathogenesis: current and future challenges.Strategies and new developments to control pertussis, an actual health problem Development of improved pertussis vaccine.Outer membrane vesicles: an attractive candidate for pertussis vaccines.Pertussis

P2860

Q34383541-F8D489B8-5D24-432C-9D6E-719C5024289F Q36226470-D80CBDF1-AF16-4C7D-800A-AE8368609F45 Q36978320-74A4F624-AA0C-4D4F-8D34-DC8CBDD2B9BB Q40410058-9BA34826-107B-4C5F-ADE0-6ADBD5153C05 Q57450944-57B3B50E-B1DE-4156-B818-6655110E4D16

P2860

An improved whole cell pertussis vaccine with reduced content of endotoxin.

http://www.wikidata.org/entity/Q37384751

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

An improved whole cell pertussis vaccine with reduced content of endotoxin.

@en

An improved whole cell pertussis vaccine with reduced content of endotoxin.

@nl

type

label

An improved whole cell pertussis vaccine with reduced content of endotoxin.

@en

An improved whole cell pertussis vaccine with reduced content of endotoxin.

@nl

prefLabel

An improved whole cell pertussis vaccine with reduced content of endotoxin.

@en

An improved whole cell pertussis vaccine with reduced content of endotoxin.

@nl

P1433

Q37384751-7EE8A59F-1644-4C49-A1F8-814A98999FC8

P1476

Q37384751-D822A75A-C15D-4B8E-BFD5-30212472B23D

P2093

Q37384751-116221A4-F242-4748-A7DC-FBC8AB7D508D

Q37384751-3C67CB8D-B8ED-403B-B7D3-2A3E7FD3C480

Q37384751-4C621175-5816-484D-A748-1D8D2485BC6A

Q37384751-698C33E2-0946-400E-A080-6DAE0BCEAE5B

Q37384751-6C84D4DE-2A69-4183-97D5-0B8DAA33F1B8

Q37384751-9BF94AFA-AA0C-4DD8-B597-7F446D5B65D6

Q37384751-B21C6F3E-A397-4277-BA6A-81124B7FAB62

Q37384751-D080A9BE-E196-490D-8468-5F0D24D83579

Q37384751-D6596D22-B3AB-4130-846E-0B93370570C0

Q37384751-D67DA05E-704A-4601-8058-81FF6973681F

P2860

Q37384751-06C6A3B9-9D06-488C-A2F4-DFE053AA68CE

Q37384751-0CF243F9-DD06-4CAC-82D5-07A00AF41549

Q37384751-27D032F1-1DFF-4661-BF32-9A34F4153DAE

Q37384751-3128BAD5-EF46-4464-9749-06B41D1DCB29

Q37384751-3B14D423-93EF-4D21-B33F-D2F959C84E99

Q37384751-3BF89221-2115-4F46-B6A9-FAFFBCD19CBC

Q37384751-3CD3CC32-2769-4029-88AC-48E741095652

Q37384751-424F8A17-8C82-42A8-9667-497FF90ECD5F

Q37384751-42895A93-8F77-4BC5-99AB-EF407569BB1B

Q37384751-45A0378A-0794-4D7F-ACA2-6C69E8626FB9

P304

Q37384751-0B3B023E-1AE2-4147-AE67-3E8C571E3DE1

P31

Q37384751-D010FFB5-9A6A-4E88-8223-660C62A0AC94

P356

Q37384751-BD188281-3C42-427B-AA55-4BD9AA134A0B

P433

Q37384751-B4B13C22-C03A-4408-8B92-D2B3A21AD8E5

P478

Q37384751-BFBD1144-7B18-4598-AC42-31255094422A

P50

Q37384751-0FA9983B-9271-459E-AC9B-A14E9A75A151

Q37384751-2E003219-0F3C-4477-B442-B0518A006D57

P577

Q37384751-19CD0CEE-3CF6-47A1-9EC8-D5BCEFCCB87E

P5875

Q37384751-2F381C52-45D8-4E76-865A-836F99579ADE

P698

Q37384751-80AA2EE6-CB36-44B6-8820-D5610F14C6E0

P921

Q37384751-D1EC88CC-3DB6-4706-AB11-023185BCAF79

P932

Q37384751-03FAF6F4-577B-4F61-8985-F4F2834179FA

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

An improved whole cell pertussis vaccine with reduced content of endotoxin

@en

P2093

Ana Fabíola R O Prestes

http://www.w3.org/2001/XMLSchema#string

Arno A J van der Ark

http://www.w3.org/2001/XMLSchema#string

Bernard A M van der Zeijst

http://www.w3.org/2001/XMLSchema#string

Betsy Kuipers

http://www.w3.org/2001/XMLSchema#string

Denise S P Q Horton

http://www.w3.org/2001/XMLSchema#string

Isaias Raw

http://www.w3.org/2001/XMLSchema#string

Maria Aparecida Sakauchi

http://www.w3.org/2001/XMLSchema#string

Marta Antoniazi

http://www.w3.org/2001/XMLSchema#string

Monamaris Marques Borges

http://www.w3.org/2001/XMLSchema#string

Noemi Furuyama

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national causes of child mortality in 2008: a systematic analysis

Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.

Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.

A rapid, small-scale procedure for the structural characterization of lipid A applied to Citrobacter and Bordetella strains: discovery of a new structural element.

Epidemiological, clinical, and laboratory aspects of pertussis in adults.

The science and fiction of pertussis vaccines.

Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.

Nonclinical vaccine safety evaluation: advantages of continuous temperature monitoring using abdominally implanted data loggers.

Development of a pertussis component vaccine in Japan.

P304

339-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.22847

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Wagner Quintilio

Flávia S Kubrusly

P577

2013-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234069639

http://www.w3.org/2001/XMLSchema#string

P698

23291935

http://www.w3.org/2001/XMLSchema#string

P921

P932

3859757

http://www.w3.org/2001/XMLSchema#string